Table 1.
Author | Diagnosis | Treatment | n | Tumor response (OR) | Complications (OR) | Local recurrence (OR) | Overall survival (OR) |
Zhou et al[47] | HCC | RFA | 744 | - | 0.29 (0.13-0.65) | 4.50 (2.45-8.27) | 0.60 (0.36- 1.01) (5 yr) |
resection | 667 | ||||||
Wu et al[50] | CLM | RFA | 273 | - | 0.32 (0.07-1.52) | 4.89 (1.73-13.87) | 0.41 (0.22-0.90) (5 yr) |
resection | 574 | ||||||
Bouza et al[63] | HCC | RFA | 396 | 1.10 (1.04-1.17) | Total: 2.55 (1.8-3.65) | 0.37 (0.23-0.59) | 1.24 (1.05-1.48) (4 yr) |
PEI | 391 | Major: 1.85 (0.68-5.01) |
PEI: Percutaneous ethanol injection; RFA: Radiofrequency ablation; OR: Odds ratio; HCC: Hepatocellular carcinoma; CLM: Colorectal liver metastases.